Related Experiment Video
Updated: Sep 20, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
MGMT in glial carcinogenesis. Roles from prevention to treatment
İlhan Elmaci1, Meric A Altinoz2, Eylem Burcu Kahraman Ozlu3
1Department of Neurosurgery, Liv Hospital.
Abstract:
Many investigations exist regarding the effect of the DNA repair enzyme MGMT (O 6 -methylguanine- DNA-methyltransferase)-encoding gene methylation on the antineoplasticity of temozolomide in glioblastoma patients. However, there exist surprisingly lesser studies regarding the associations between MGMT enzyme biochemistry with glial carcinogenesis. MGMT involves in risk of malignancies associated with ionizing radiation, smoking, exposure to polycyclic aromatic hydrocarbons, chlorinated solvents, vinylchloride and hairdyes. All these factors are also proposed to link with gliomagenesis, yet MGMT interactions with these carcinogens in gliomagenesis are not studied yet. In future, MGMT sequencing may be employed in vulnerable populations working in industries associated with exposure to these carcinogens to develop preventive strategies. Given that MGMT is involved in DNA repair, a polymorphism may simultaneously modify the risk of gliomas while enhancing temozolomide cytotoxicity in both marrow and tumor cells.
Insights
Investigating the O-6-methylguanine-DNA-methyltransferase (MGMT) enzyme
Area of Science:
- Neuroscience
- Oncology
- Biochemistry
Background:
- The DNA repair enzyme O-6-methylguanine-DNA-methyltransferase (MGMT) and its gene methylation are extensively studied for their role in glioblastoma treatment with temozolomide.
- However, the association between MGMT enzyme biochemistry and the development of glial tumors (gliomagenesis) remains under-researched.
Purpose of the Study:
- To explore the understudied link between MGMT enzyme biochemistry and gliomagenesis.
- To investigate the role of MGMT in malignancies linked to environmental carcinogens and its potential connection to glioma development.
Main Methods:
- Literature review and analysis of existing research on MGMT, carcinogen exposure, and gliomagenesis.
- Exploration of potential MGMT interactions with environmental factors implicated in glioma development.
Main Results:
- MGMT is implicated in DNA repair and its activity is influenced by gene methylation, affecting temozolomide efficacy in glioblastoma.
- Environmental factors like ionizing radiation, smoking, polycyclic aromatic hydrocarbons, and certain chemicals are linked to both MGMT-associated malignancies and gliomagenesis.
- Direct studies on MGMT's interaction with these specific carcinogens in the context of gliomagenesis are currently limited.
Conclusions:
- There is a need for further research into the biochemical interactions of MGMT with environmental carcinogens to understand their role in gliomagenesis.
- Future MGMT sequencing in high-risk populations exposed to carcinogens could inform preventive strategies against gliomas.
- MGMT polymorphisms may influence both glioma susceptibility and response to temozolomide therapy.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
09:44Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
Published on: November 20, 2012